Lauren Ross
Psychiatric/Mental Health · Madison, ALNPI 1801348248
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 346 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations.
Across 346 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$759
- Neurocrine Biosciences, Inc.$647
- Alkermes, Inc.$573
- Otsuka America Pharmaceutical, Inc.$570
- Axsome Therapeutics, Inc.$435
- plus $2K from 17 others
What the payments were for
- Food & beverage$6,51099%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $1,236 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 48 | $759 |
| Neurocrine Biosciences, Inc. | 28 | $647 |
| Alkermes, Inc. | 24 | $573 |
| Otsuka America Pharmaceutical, Inc. | 30 | $570 |
| Axsome Therapeutics, Inc. | 31 | $435 |
| Johnson & Johnson | 19 | $389 |
| Lundbeck LLC | 21 | $385 |
| Vanda Pharmaceuticals Inc. | 15 | $314 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $177 |
| Teva Pharmaceuticals USA, Inc. | 9 | $171 |
| Neos Therapeutics, LP | 9 | $149 |
| Corium, LLC | 8 | $133 |
| Almatica Pharma LLC | 6 | $122 |
| Tris Pharma Inc | 6 | $115 |
| Supernus Pharmaceuticals, Inc. | 6 | $112 |
| Eisai Inc. | 5 | $76 |
| Adlon Therapeutics L.p. | 4 | $58 |
| Indivior Inc. | 2 | $50 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Pear Therapeutics (US), Inc. | 1 | $22 |
| Alfasigma USA, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $15 |
How this compares
$6,557 in reported general payments places this provider in the 85th percentile of 378 psychiatric/mental health providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 18 | $24,366 |
| Bupropion XlBupropion Hcl | 15 | $389 |
| Buspirone Hcl | 16 | $326 |
| Duloxetine Hcl | 18 | $319 |
| Lamotrigine | 23 | $315 |
| Trazodone Hcl | 30 | $241 |
| Quetiapine Fumarate | 12 | $195 |
| Alprazolam | 19 | $73 |
| Clonazepam | 22 | $41 |
| Fluoxetine Hcl | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,236 | $24,36618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 378 psychiatric/mental health providers in Alabama.
Other psychiatric/mental health in Madison
- Keith WattsMadison$13K
- Michelle PrattMadison$13K
- Stephanie KitchenMadison$9K
- Stephanie McLaughlinMadison$8K
- William CrainMadison$7K
- Angela WaldropMadison$6K
- Kelly GreerMadison$6K
- Laura GrahamMontgomery$80K
- Yuliya SpencerBirmingham$65K
- Keri BarrBay Minette$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.